CHRNB1

Cholinergic Receptor Nicotinic Beta 1 Subunit

Gene Information Card

Symbol CHRNB1
Full Name Cholinergic Receptor Nicotinic Beta 1 Subunit
Gene Type protein-coding
Chromosomal Location 17p13.1
NCBI Gene ID 1140 ncbi.nlm.nih.gov/gene/1140
Ensembl ID ENSG00000170175
UniProt ID P11230
OMIM ID 100710
HGNC ID 1961
Aliases ACHRB, CHRNB, CMS2A, CMS2C, SCCMS

Description

CHRNB1 (cholinergic receptor nicotinic beta 1 subunit) encodes the beta subunit of the muscle-type nicotinic acetylcholine receptor (nAChR), a pentameric ligand-gated ion channel expressed at the neuromuscular junction. This subunit is essential for receptor assembly and function. Mutations in CHRNB1 are associated with congenital myasthenic syndromes (CMS), including slow-channel and fast-channel syndromes, and with a rare form of autosomal dominant nocturnal frontal lobe epilepsy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital Myasthenic Syndrome 2A (slow-channel) Missense mutations in the transmembrane domain prolong channel open time, causing calcium overload and endplate degeneration. ClinVar, OMIM #616313
Congenital Myasthenic Syndrome 2C (fast-channel) Mutations reduce acetylcholine affinity or channel opening probability, leading to reduced synaptic response. ClinVar, OMIM #616323
Myasthenic Syndrome, Congenital, 2B (with tubular aggregates) Specific missense variants impair receptor clustering and cause structural abnormalities at the neuromuscular junction. OMIM #616324

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle 28.5 High
Heart 2.1 Low
Brain 0.8 Low
Liver 0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
RH-30 (rhabdomyosarcoma) 15.3 Moderate
HSMM (skeletal muscle myoblasts) 22.7 High
SH-SY5Y (neuroblastoma) 0.5 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.121C>T (p.Arg41Trp) Missense <0.01% Slow-channel CMS; gain-of-function
c.820G>A (p.Glu274Lys) Missense <0.01% Fast-channel CMS; loss-of-function
c.1327G>A (p.Val443Met) Missense <0.01% Slow-channel CMS; gain-of-function
Mutation functional classification

Loss of Function (LOF)

Fast-channel CMS variants (e.g., p.Glu274Lys) reduce acetylcholine binding affinity or channel opening, decreasing synaptic response.

Gain of Function (GOF)

Slow-channel CMS variants (e.g., p.Arg41Trp, p.Val443Met) prolong channel open time, causing excitotoxicity and endplate degeneration.

Dominant Negative (DN)

Some missense mutations in the extracellular domain impair receptor assembly, reducing surface expression of functional pentamers.

Pathways

Nicotinic acetylcholine receptor signaling (Reactome: R-HSA-622327)
Neurotransmitter receptor binding and downstream transmission (Reactome: R-HSA-112314)
Acetylcholine binding and channel opening (KEGG: hsa04725)

Protein Summary

The CHRNB1 protein (UniProt P11230) is a 501-amino acid transmembrane subunit of the muscle nicotinic acetylcholine receptor. It contains an extracellular N-terminal domain, four transmembrane helices (M1-M4), and a large intracellular loop between M3 and M4. The beta subunit contributes to the acetylcholine-binding site at the interface with alpha subunits and is critical for channel gating. Post-translational modifications include N-glycosylation and phosphorylation, which modulate receptor trafficking and function.

Related Products

Product name Cat.No. Species Gene ID
CHRNB1 Knockout HEK293 Cell Line EDJ-KQ4280 Human 1140 Details Get a Quote
CHRNB1 Knockout HCT 116 Cell Line EDJ-KQ25461 Human 1140 Details Get a Quote
CHRNB1 Knockout A-549 Cell Line EDJ-KQ26762 Human 1140 Details Get a Quote
CHRNB1 Knockout HeLa Cell Line EDJ-KQ26764 Human 1140 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: